$2500 | Single User
$5000 | Site License
$7500 | Enterprise License

Kidney Transplant Rejection Global Clinical Trials Review, H2, 2016
[Lowest Price Guaranteed: $2,500]

Published by Global Data: 30 Sep 2016 | 27757 | In Stock
Related Topics: Clinical Trials

Introduction

Kidney Transplant Rejection Global Clinical Trials Review, H2, 2016

Summary

GlobalData's clinical trial report, “Kidney Transplant Rejection Global Clinical Trials Review, H2, 2016" provides an overview of Kidney Transplant Rejection clinical trials scenario. This report provides top line data relating to the clinical trials on Kidney Transplant Rejection. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Kidney Transplant Rejection Global Clinical Trials Review, H2, 2016

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 4

    Report Guidance 5

    Clinical Trials by Region 6

    Clinical Trials and Average Enrollment by Country 7

    Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9

    Top Five Countries Contributing to Clinical Trials in Europe 10

    Top Countries Contributing to Clinical Trials in North America 11

    Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12

    Top Five Countries Contributing to Clinical Trials in Central and South America 13

    Clinical Trials by G7 Countries: Proportion of Kidney Transplant Rejection to Immunology Clinical Trials 14

    Clinical Trials by Phase in G7 Countries 15

    Clinical Trials in G7 Countries by Trial Status 16

    Clinical Trials by E7 Countries: Proportion of Kidney Transplant Rejection to Immunology Clinical Trials 17

    Clinical Trials by Phase in E7 Countries 18

    Clinical Trials in E7 Countries by Trial Status 19

    Clinical Trials by Phase 20

    In Progress Trials by Phase 21

    Clinical Trials by Trial Status 22

    Clinical Trials by End Point Status 23

    Subjects Recruited Over a Period of Time 24

    Clinical Trials by Sponsor Type 25

    Prominent Sponsors 26

    Top Companies Participating in Kidney Transplant Rejection Therapeutics Clinical Trials 27

    Prominent Drugs 29

    Latest Clinical Trials News on Kidney Transplant Rejection 30

    Oct 03, 2016: Hansa Medical: First Patient Treated in Hansa Medical’s Highdes-Study 30

    Aug 23, 2016: Top line results from the Swedish ongoing Phase II study with IdeS in sensitized patients presented 30

    Jul 29, 2016: TRACT Therapeutics Presents Follow-Up Phase I Clinical Data in Kidney Transplant Recipients at the American Transplant Congress 2016 31

    Clinical Trial Profile Snapshots 32

    Appendix 736

    Abbreviations 736

    Definitions 736

    Research Methodology 737

    Secondary Research 737

    About GlobalData 738

    Contact Us 738

    Disclaimer 738

    Source 739

List Of Tables
in Kidney Transplant Rejection Global Clinical Trials Review, H2, 2016

List of Tables

Kidney Transplant Rejection Therapeutics, Global, Clinical Trials by Region, 2016* 6

Kidney Transplant Rejection Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7

Kidney Transplant Rejection Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8

Kidney Transplant Rejection Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9

Kidney Transplant Rejection Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10

Kidney Transplant Rejection Therapeutics Clinical Trials, North America, Top Countries, 2016* 11

Kidney Transplant Rejection Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 12

Kidney Transplant Rejection Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 13

Proportion of Kidney Transplant Rejection to Immunology Clinical Trials, G7 Countries (%), 2016* 14

Kidney Transplant Rejection Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15

Kidney Transplant Rejection Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16

Proportion of Kidney Transplant Rejection to Immunology Clinical Trials, E7 Countries (%), 2016* 17

Kidney Transplant Rejection Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18

Kidney Transplant Rejection Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19

Kidney Transplant Rejection Therapeutics, Global, Clinical Trials by Phase, 2016* 20

Kidney Transplant Rejection Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21

Kidney Transplant Rejection Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22

Kidney Transplant Rejection Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23

Kidney Transplant Rejection Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24

Kidney Transplant Rejection Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25

Kidney Transplant Rejection Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26

Kidney Transplant Rejection Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28

Kidney Transplant Rejection Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29

List Of Figures, Charts and Diagrams
in Kidney Transplant Rejection Global Clinical Trials Review, H2, 2016

List of Figures

Kidney Transplant Rejection Therapeutics, Global, Clinical Trials by Region (%), 2016* 6

Kidney Transplant Rejection Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7

Kidney Transplant Rejection Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8

Kidney Transplant Rejection Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9

Kidney Transplant Rejection Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10

Kidney Transplant Rejection Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11

Kidney Transplant Rejection Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 12

Kidney Transplant Rejection Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 13

Proportion of Kidney Transplant Rejection to Immunology Clinical Trials, G7 Countries (%), 2016* 14

Kidney Transplant Rejection Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15

Kidney Transplant Rejection Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16

Proportion of Kidney Transplant Rejection to Immunology Clinical Trials, E7 Countries (%), 2016* 17

Kidney Transplant Rejection Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18

Kidney Transplant Rejection Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19

Kidney Transplant Rejection Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20

Kidney Transplant Rejection Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21

Kidney Transplant Rejection Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22

Kidney Transplant Rejection Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23

Kidney Transplant Rejection Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24

Kidney Transplant Rejection Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25

Kidney Transplant Rejection Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26

Kidney Transplant Rejection Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27

Kidney Transplant Rejection Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29

GlobalData Methodology 737

Additional Details

Publisher

Global Data

Publisher Information

Reference

27757 | GDHC3820CTIDB

Number of Pages

739

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global Chronic Kidney Disease Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Nov 2016 by Current Partnering USD $1,495 More Info
Global Chronic Kidney Disease Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Kidney Transplant Rejection Global Clinical Trials Review, H2, 2016
Kidney Transplant Rejection Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical tria...
30 Sep 2016 by Global Data USD $2,500 More Info
Urology Surgical Instruments Market by Product (Endoscopes, Endovision Systems, Peripheral Instruments, Consumables and Accessories), Application (Chronic Kidney Diseases, Benign Prostatic Hyperplasia, Oncology) - Global Forecast to 2021
The global urology surgical instruments market is expected to reach USD 11.48 billion by 2021 from U...
01 Sep 2016 by MarketsandMarkets USD $5,650 More Info
Organ-on-Chip Global Market 2010-2020 Including: Lung-on-chip, Heart-on-chip, Liver-on-chip, Intestine-on-chip, Kidney-on-chip and Human-on-chip, Human disease and tissue models, Microfluidics Historic and Forecast 2010 – 2020 Covering: North America, Europe, Rest Of World (ROW)
Organ-on-chips or organ-on-a-chips (OOCs) are microfluidic 3D cell culture devices that closely mimi...
30 May 2016 by The Business Research Company USD $4,000 More Info
Hospitals and Outpatient Care Centers Global Market Analytics Report 2016 Including: Freestanding Ambulatory Surgical and Emergency Centers, General Medical and Surgical Hospitals, HMO Medical Centers, All Other Outpatient Care Centers, Kidney Dialysis Centers Historic and Forecast Growth Rate 2011 – 2019 Analysing: Expenditure Per Capita, Expenditure Per Household, Government Expenditure, Healt
The Hospitals and Outpatient Care Centers Market Analytics Report provides strategists, marketers an...
23 May 2016 by The Business Research Company USD $2,000 More Info
Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2016
Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2016SummaryGlobal...
20 Apr 2016 by Global Data USD $2,500 More Info
Hyperphosphatemia In Chronic Kidney Disease Global Clinical Trials Review, H2, 2015
Hyperphosphatemia In Chronic Kidney Disease Global Clinical Trials Review, H2, 2015SummaryGlobalData...
25 Nov 2015 by Global Data USD $2,500 More Info
Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H2, 2015
Chronic Kidney Disease (Chronic Renal Failure) Global Clinical Trials Review, H2, 2015SummaryGlobalD...
30 Oct 2015 by Global Data USD $2,500 More Info
Chronic Kidney Disease - Pipeline Analysis
“Chronic Kidney Disease (CKD) Pipeline Analysis” gives comprehensive insight on the various drugs be...
07 May 2015 by IQ4I USD $3,600 More Info

This report is published by Global Data

Download Free Report Summary PDF

Kidney Transplant Rejection Global Clinical Trials Review, H2, 2016 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...